The K@W Network:
While pharmaceutical companies hope their television ads might convince a consumer to choose their drug over a rival’s, new Wharton research finds that the ads have a number of additional,[…]
Consumers today often belong to a host of retail ‘loyalty programs,’ earning redeemable points when they spend. So why do so many people stockpile points instead of using them?
After a corporate spin-off, members of the parent firm’s board are often placed on the board of the divested firm. But what does it mean for a newly created company[…]
In normal years, investing in equities can reap extremely healthy returns. But not all of that ROI is based on what you'd think. Some of it is rooted in the[…]
If we were rational, we would make choices based on long-term goals, not short-term desires. But that’s not always the case. New research by Wharton’s Howard Kunreuther suggests ways to[…]
A year after the Supreme Court’s Hobby Lobby decision, a big question remains: How far do corporate religious rights go? Wharton’s Amy Sepinwall offers some answers in two recent papers.
A new e-book co-authored by Wharton professor Kevin Werbach offers ideas for using game elements to engage customers, employees and others.
Are the FDA's medical device regulations too hard, too soft, or just right? Wharton research indicates that the agency is on the right track.
Wharton finance professor Philipp Illeditsch and colleagues have created a model that captures a valuable new way to value bonds, based on volatility and risk premiums.
Bragging about generous deeds could bring individuals praise or scorn, depending on their motivations, says Wharton’s Deborah Small.